Sana Biotechnology Inc (SANA)
9.78
+0.16
(+1.66%)
USD |
NASDAQ |
May 02, 16:00
9.78
0.00 (0.00%)
After-Hours: 19:20
Sana Biotechnology Shareholders Equity (Quarterly): 287.51M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 287.51M |
| September 30, 2023 | 365.85M |
| June 30, 2023 | 355.03M |
| March 31, 2023 | 428.26M |
| December 31, 2022 | 499.32M |
| September 30, 2022 | 566.02M |
| June 30, 2022 | 639.50M |
| March 31, 2022 | 701.66M |
| Date | Value |
|---|---|
| December 31, 2021 | 728.50M |
| September 30, 2021 | 830.08M |
| June 30, 2021 | 905.90M |
| March 31, 2021 | 881.98M |
| December 31, 2020 | -421.18M |
| September 30, 2020 | -311.18M |
| December 31, 2019 | -142.54M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-421.18M
Minimum
Dec 2020
905.90M
Maximum
Jun 2021
420.98M
Average
499.32M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Rocket Pharmaceuticals Inc | 492.57M |
| Solid Biosciences Inc | 126.48M |
| Dyne Therapeutics Inc | 91.29M |
| Taysha Gene Therapies Inc | 74.94M |
| Tenaya Therapeutics Inc | 139.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 565.30M |
| Total Liabilities (Quarterly) | 277.79M |